Background This study of cancer survival compared adults in Toronto, Ontario and three US metropolitan areas: Seattle, Washington; San Francisco, California; and Hartford, Connecticut. It examined whether socioeconomic status has a differential effect on cancer survival in Canada and the United States.
Introduction
Nine of ten recent US studies on cancer survival have found a signi®cant survival disadvantage with low socioeconomic status (SES). Cumulative survival rates among patients of relatively high SES were found to be 47 per cent greater than among their lower status counterparts.
1 A similar association between SES and cancer survival, although of attenuated magnitude (17 per cent differential), has also been observed in recent studies carried out in other developed continental European and Nordic countries as well as Australia. 2±15 Interestingly, such an aggregate socioeconomic cancer survival association has not been observed among three Canadian cohorts (nonsigni®cant 3 per cent differential).
1, 16, 17 Health care system differences, such as the greater representation of universal single-payer systems in Europe and Canada, may parsimoniously account for the greatly diminished to null SES±cancer survival associations found in these countries as compared with the United States. Even among European countries, however, substantial cancer survival variabilities have been observed. 18±23 The concomitant tendencies for the so-called EUROCARE and related studies to demonstrate advantaged survival among more developed western and Nordic European countries whereas they found somewhat disadvantaged survival among countries such as England with multi-tiered health care systems, which include substantially developed private components, are again consistent with health care systemic explanations. It seems that speci®c planned comparisons of cancer outcomes in different countries can provide valuable clues about the relative effectiveness of their respective health care systems. The present study analyses one such North American comparison of Canada and the United States.
A recent study of cancer survival in Toronto, Ontario and Detroit, Michigan, compared their ecologically de®ned poor, that is, those who live in relatively low-income areas. It found advantaged survival among Canadians for 13 of 15 cancer sites.
1 Moreover, no such between-country differentials were observed in their middle-or high-income areas. The only other Canada±United States comparative study in this ®eld found their cancer survival experience to be substantively similar. 24 Its essentially nonsigni®cant ®ndings are not surprising, however, as it did not include any measure of socioeconomic status. It merely compared cohorts across all levels of SES together, and so could not observe any modi®cation of betweencountry survival differences by SES. Even the more recent study, by comparing samples of both countries' relatively poor as de®ned by the lowest third of their neighbourhoods on average income, only provided rather gross absolute SES adjustment.
1 The median annual household income among the poorest third of their populations was signi®cantly less in Detroit than in Toronto ($17 800 versus $30 400 US dollars in 1990). In other words, the poor of Detroit's relatively poor neighbourhoods tend to be poorer than their Toronto counterparts, and this absolute income difference, rather than differential access to preventive and therapeutic health care services among those with relatively low incomes, could possibly explain the observed Canadian survival advantage. The present analysis systematically replicates this between-country cancer survival comparison with three more economically advantaged US metropolitan areas. In so doing it will provide more precise ecological control for absolute income status. We hypothesized that after such adjustment, relatively poor Canadians would continue to enjoy advantaged cancer survival over their similarly poor US counterparts.
Methods
Cancer cases arose from the populations of metropolitan Toronto, Ontario (3.5 million in 1991) and the combined US metropolitan areas of Seattle, Washington; San Francisco, California; and Hartford, Connecticut (4.8 million in 1990). 25, 26 Cancer surveillance in Toronto is demonstrably the most complete and valid in Canada. It also offers an external validity bene®t in that one of every seven Canadian residents lives in the greater metropolitan Toronto area.
1, 27 The three US cities were selected because they are the most economically advantaged (median household income) of the large cities (one million or more residents) sampled by the National Cancer Institute's Surveillance, Epidemiology and End Results (SEER) programme. 28 To provide some control for natural health care service endowment, and also because the original Toronto cohort was de®ned by a three county area, the three US metropolitan samples were each restricted to their three most central counties.
Primary malignant adult cancer cases among the 15 most common sites arising in the Toronto [23 437 cases; Ontario Cancer Registry (OCR)] and US (37 329; SEER registry programme) cohorts from 1986 to 1988 were followed until 31 December 1993. Both registries have been estimated to ascertain 97 per cent or more of all incident cases. 29, 30 As did the original, the present analysis used a census-based SES measure [census tract proportion meeting a`low-income' criterion in Canada and`poverty' threshold in the United States (percentage poor)] to de®ne relative income tertiles. 25, 26 The analytic goal for the use of such census-based socioeconomic measures was simply the aggregation of cancer cases in each country into three approximately equivalent population thirds, that is, relatively low-, middle-and high-income areas. We were then able to ask the more focused, and we think, policy-interesting question: Among the relatively poor (those who live in equally poor neighbourhoods), do Canadians experience survival advantages across the most common types of cancer? Thus, the critical comparison was between Toronto's poor (lowest-income third, 244 census tracts, median household income of $30 400 US dollars) and the US cohort's similarly poor areas (lowest-income third, 354 census tracts, median household income of $29 300). As intended, this sampling strategy provided substantial control for absolute economic status. Critical comparison groups ± relatively poor Canadians versus relatively poor US residents ± as assessed by typical household income, had nearly identical average economic statuses. Finally, this study's US cohort was a near exact replicate of the original Toronto and Detroit cohorts on data quality indicators: 97.1 per cent of their census tract residences at the time of diagnosis were coded, 94.4 per cent of the cancers were microscopically con®rmed, and 0.9 per cent were enumerated on the basis of death certi®cates only. 28 Methodologically, the present study's 5 year survival analysis was an exact replicate of the original: the same 15 cancer sites were used (ICD-9 codes) and survival rates were directly age-adjusted using this study's combined Toronto±US population of cases by each speci®c cancer site across the following age strata: 25±44, 45±54, 55±64, 65±74 and 75 years of age or older. Nearly all of the between-country age strata differences were less than 5 per cent; only two of them were greater than 8 per cent. Cancer survival comparisons of Canadian and US residents of low-income areas were then accomplished so that the survival rate ratio was greater than 1.00 if Toronto residents were advantaged and less than 1.00 if US residents were. The poor of the three US cities did not differ signi®cantly on total cancer survival, so their ®ndings were aggregated. Con®dence intervals (95 per cent) around survival rate ratios were based on the Mantel±Haenszel x 2 test.
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Results
The two countries did not differ signi®cantly on cancer survival in the aggregated middle-and high-income groups. This study's central analysis, the comparison of Toronto and the United States on 5 year cancer survival among the poorest third of their respective populations, is displayed to the left side in 
Discussion
We studied the effect of socioeconomic status on survival from the 15 most common types of cancer among the adult populations of Toronto, Ontario, and three US metropolitan areas. Between-country analysis, which compared cases arising from Toronto and the US cities' low-income areas, found a signi®cant Toronto survival advantage for 13 of 15 cancer sites. Furthermore, this consistent pattern of Toronto advantage was maintained even with a very conservative comparison of only puts these ®ndings into a provocative, and we think informative, lifespace context. Some of the between-country survival rate ratios were attenuated somewhat as compared with those previously observed in the Toronto±Detroit comparison. However, it ought to be noted that the small to moderate relative risk estimates of from 10 to 50 per cent, typical among this study's ®ve or six most common cancers, could, if the hypothesized health care payer factor is ultimately found to be causal, represent very large population attributable risks. Having provided more precise ecological adjustments for absolute income status and race than previous studies have, we believe that this study points toward structural differences between Canada and the United States (single versus multi-payer health care systems) as the most cogent explanation for its ®ndings. Systematically replicating a previous Toronto±Detroit comparison, this study's observed consistent pattern of Canadians' survival advantage across various cancer sites suggests that their more equitable access to preventive and therapeutic health care services is responsible for the difference.
Minimally, this study con®rms that the consistent pattern of Canadian cancer survival that was found in the original hypothesis-generating Toronto±Detroit study is probably not explainable by any Detroit-speci®c phenomena. In that the present study is observational with respect to country and ecological with respect to socioeconomic measurement, at most, it may serve to clearly focus attention on the structural, health care systems theory. Although its ®ndings certainly do not substantiate a causal claim for the single payer Canadian health care system, it has gone beyond mere hypothesis generation. For example, this study, along with the original one, essentially represents 60 systematic replications across diverse types of cancer in a variety of contexts: 15 common cancers by four paired city comparisons (Toronto versus Detroit, Seattle, San Francisco and Hartford). Among the relatively poor, Canadian survival advantage was observed for 52 of these 60 comparisons. Such Canadian advantage does not seem to be related to personal nor biological cancer correlates. Cancers with diverse hypothesized component causes (genetic, environmental and lifestyle) and prognoses (relatively good to poor) seem to be similarly affected. Furthermore, US cancer survival disadvantage has been consistently observed in four very diverse metropolitan areas. These four places differ signi®cantly on numerous social and environmental characteristics such as racial and ethnic distributions, degree of residential segregation, major industries and associated job markets, health care service endowments (hospital and physician distributions), major health insurers, and climate, to name a few. Yet their lower cancer survival rates as compared with Toronto's are strikingly similar. For a factor to be able to account for this international cancer survival pattern it must systematically differ between Toronto and all four of the US cities studied thus far, and also be consistently similar across these four US locales. Universality of access to the single payer Canadian system seems to us the most potent plausible explanation.
Possible alternative explanations
This study's socioeconomic variable was census tract based, so it is ecological with respect to income measurement. Its analytic goal was not, however, to assign individual cases a speci®c income based on their census tract of residence as a proxy, but rather, to assign them to one of three broad socioeconomic classi®cations: reside in relatively low-, middle-or high-income areas. The information bias that may intrude because the socioeconomic exposure variable is measured ecologically is clearly far less potent when aggregating cancer cases into three rank-ordered socioeconomic areas, as this study did, than when such ecological measures are analytically employed as more direct proxies for each individual's SES. 39±42 The ecological fallacy notwithstanding, we believe it is important to simply know that where people with cancer live, speci®cally, among those who live in areas where people with low incomes tend to be concentrated, seems to be highly associated with how long they live in the United States, but not in Canada. This study's contextual inferences are thus most relevant to understanding community-level phenomena such as systemic environmental factors that differ between the countries.
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A number of other factors potentially confound this study's between-country cancer survival comparison among those who live in relatively poor areas. For example, it has already been mentioned that younger Canadians as compared with their US counterparts are more advantaged on cancer survival than older Canadians are. Although, as one might expect, Medicare coverage in the United States tends to buffer the health disadvantages of being poor, it still does not seem to be as effective as the experience of universal access to health care over the life course. This study's cohort of Canadian cancer patients 65 years of age or older who live in relatively poor areas were still found to enjoy an overall 17 per cent cancer survival advantage as compared with similarly older and poorer US residents (SRR 1.17, 95 per cent CI 1.14±1.20). Relatedly, one may ask about another categorical health care programme in the United States ± Medicaid: are not the poor adequately covered through it? It ought to be recalled that this study compared the lowest one-third of income areas among its Canadian and US samples. In the United States, for example, such areas do not only include severely degraded inner-city areas of highly concentrated impoverishment, but also working class and even middle class neighbourhoods. In fact, among this study's low-income US sample, 19 per cent of its population is poor according to federally established criteria, and so is eligible for Medicaid coverage, whereas nearly a third each are near poor (up to 200 per cent of the of®cial poverty threshold) or lower middle class (incomes between the 20th and 40th percentiles). 26 Problems of continuity and quality of care with Medicaid coverage notwithstanding, it is precisely these groups of people who are at the greatest risk of being uninsured or underinsured. Another bias is possible because deaths of SEER cases are identi®ed by linkage to US national death records, but Toronto, Ontario, cases are linked to provincial death records only. However, because over the life of this study's cohort only 1±3 per cent of all prior Toronto residents moved out of the province and such moves are even less likely among people with chronic health conditions such as cancer who live in relatively poor neighbourhoods (r 0.12), any effects on this study's between-country survival rate ratios among cancer patients in low-income areas are likely to be on the order of magnitude of one-and two-hundredths of a decimal place, and therefore, practically inconsequential. 25, 44, 45 Finally, lifestyle factors such as diet, alcohol consumption and smoking, which have been observed to be strongly associated with cancer occurrence, are only weakly associated with cancer survival, if at all.
4±6,46±51 It is unlikely that these personal factors could account for the consistently observed survival differences across such different types of cancer. In conclusion, qualitative elucidation of possible alternative explanations tends to further support, rather than refute, the plausibility of the health care systems explanation for observed international differences on cancer survival.
